There are no guidelines regarding the best practice for when Barrett ' s esophagus (BE) is suspected but not confi rmed by histology. The aim of this study was to examine the value of endoscopic follow-up for individuals with endoscopic only BE at index endoscopy.
INTRODUCTION
Th e diagnostic criteria for Barrett ' s esophagus (BE) are debated among experts. Th e diffi culty in determining the metaplastic nature of columnar epithelium in the distal esophagus coupled with the unreliability of endoscopic determination of the distal extent of the esophagus ( 1, 2 ) are the main reasons for the debate. Th e epithelium detected in targeted biopsies of endoscopically suspected BE may contain gastric fundic glands, gastric cardia, or intestinal-type epithelium-containing goblet cells ( 3 ) . Th e latter type of epithelium is considered essential for the defi nition of BE. However, given the possibility of sampling errors, IM may be missed when present in the esophagus or alternatively may be present in the cardia of the stomach usually as a result of Helicobacter pylori infection ( 4 ) .
Practice guidelines from the American College of Gastroenterology recommend that BE diagnosis is made by a combination of endoscopic diagnosis with confi rmation of IM on histopathology. Th ese guidelines also suggest performing two esophagogastroduodenoscopies (EGD) within 1 year with targeted biopsies from suspected areas for confi rmation of the BE diagnosis and ruling out dysplasia ( 5 ) . However, there are currently no recommendations on the need or frequency of follow-up for patients with a negative Barrett ' s Esophagus Suspected at Endoscopy but No Specialized Intestinal Metaplasia on Biopsy, What ' s Next ?
or indeterminate histopathology for BE in patients with suspected BE based on endoscopic fi ndings.
Neither the prevalence of endoscopic BE only (in the absence of specialized intestinal metaplasia (IM)) nor the reliability of this diagnosis are clear. Th e Munich BE follow-up study showed that only 11 % of 49 patients with an index endoscopy showing suspected columnar lined esophagus (CLE) without IM had a subsequent confi rmatory diagnosis by endoscopy and histology performed at least 1.5 years following the initial examination ( 6 ) . However, this study evaluated a relatively small number of such patients, and the multicenter setting of the study with several endoscopists and histopathologists may have aff ected the consistency of the reported fi ndings. More studies are required to defi ne the prevalence of the entity of suspected CLE without IM and the reliability of diagnosis on follow-up.
Given the poorly understood prevalence and short-term outcome of suspected CLE without IM, we examined patients enrolled in a prospective single-center study who were systematically and uniformly screened for BE. In patients whose index endoscopy was suspicious for BE (i.e., suspected CLE) but unconfi rmed by histology (i.e., no IM), we performed a follow-up repeat endoscopy with esophageal biopsy to determine BE status.
METHODS

Study population and design
We performed a longitudinal study at the Michael E. DeBakey VA Medical Center (MEDVAMC) in Houston, TX among patients with endoscopic only BE.
Th is study was nested within a large single-center study that prospectively enrolled patients to determine prevalence and risk factors for BE. Methods are reported elsewhere ( 7 ), but briefl y we recruited all eligible patients who were scheduled for an elective EGD at MEDVAMC. We also recruited eligible patients from seven selected primary care clinics at the same hospital between 1 September 2008 and 31 December 2010. Th e patients who were scheduled for an elective EGD were 92.4 % male, 30.4 % AfricanAmerican, 65 % White, and 4.6 % other race, and the mean age was 60.5 (s.d. = 8.5) years. Th e patients recruited from elective EGD were 91 % male, 28.7 % African-American, 68.6 % White, and 2.8 % other race, and their mean age was 59.9 (s.d. = 8.4) years.
Th e eligibility criteria were: (1) age between 40 -80 years; (2) no previous gastro-esophageal surgery; (3) no previous cancer of the esophagus; (4) no active lung, liver, colon, breast, or stomach cancer; (5) not currently taking anticoagulants; (6) no signifi cant liver disease indicated by platelet count >70 × 10 3 / mm 3 , ascites, or known gastro-esophageal varices; and (7) no history of major stroke or mental condition that would limit their ability to answer questions. For the primary care group, we invited patients who were eligible for screening colonoscopy to participate in this study and undergo a study EGD at the same time as their colonoscopy. Th e same eligibility criteria were used with the exception of the lower age limit, which was raised to 50 years.
Th is research was approved by the Institutional Review Boards for the MEDVAMC and Baylor College of Medicine.
Data collection
All study participants underwent an EGD with systematic recording of suspected CLE if there was a visualized extension of possible columnar epithelium into the distal esophagus and proximal to the beginning of the gastric folds. Suspected CLE was classifi ed using the Prague (circumferential) and M (maximal extent) classifi cation ( 8 ) . Depending on the length and confi guration of the suspected CLE segments, four quadrant biopsies at intervals of 2 cm from suspected CLE areas were taken using jumbo biopsy forceps. From short CLE segments, at least one biopsy had to be obtained from each tongue of suspected CLE and at least two biopsies from any circumferential suspected BE. Two expert pathologists reviewed all slides. Defi nitive BE was defi ned as the presence of IM in the histopathological examination of biopsy samples obtained from suspected CLE areas. CLE without IM only was defi ned by the presence of endoscopically suspected CLE in the absence of IM on histopathology.
Patients with suspected CLE on endoscopy and no IM on histopathology were invited for a follow-up EGD with biopsies within 2 years of the initial examination. Th e follow-up endoscopy was carried out in the same manner with review of biopsies by two expert pathologists. We also collected the identity of the endoscopist performing the index as well as follow-up endoscopy.
Data analysis
We calculated the prevalence of suspected CLE from the index study EGD among study participants. We examined the three possible outcomes (defi nite BE, CLE without IM, or no CLE) on the repeat EGD in patients with an index EGD showing suspected CLE with no IM on histopathological evaluation. We calculated the proportions and the accompanying 95 % confi dence intervals (CIs) of patients with these outcomes. We also examined the possible determinants of suspected CLE on the index EGD and three possible outcomes on repeat EGD. Th e potential determinants included demographic (age, sex, race), clinical (body mass index, presence of gastro-esophageal refl ux disease (GERD), proton pump inhibitor intake, histamine-2 receptor antagonist intake, non-steroidal anti-infl ammatory drug use), endoscopic features (maximum length of CLE, hiatus hernia, Hill ' s classifi cation of the gastro-esophageal fl ap valve), and the endoscopist ' s identity. Defi nitions for these variables were reported in our previous manuscripts ( 7, 8 ) .
Statistical analysis was carried out using the Chi-square tests for categorical variables and the Wilcoxon ' s test for continuous variables. Logistic regression models were used for multivariable adjustment. Parameter estimates and s.es. from the model were used to calculate odds ratios (OR) and their accompanying 95 % CIs.
RESULTS
A total of 1,844 participants underwent EGD as part of the study; 1,263 (68 % ) were referred for elective EGD and 581 (32 % ) were patients recruited from primary care for EGD and colonoscopy. Suspected CLE was recorded in 344 (19 % ) subjects on the index endoscopy ( Figure 1 ). Of these, 237 (13 % of the total study population) were found to have defi nite BE on histopathology (IM) and the rest were CLE without IM. Among patients with defi nite BE, 146 (62 % ) had short segment ( < 3 cm) BE and 91 (38 % ) had long segment. At least one esophageal biopsy was obtained from all patients. Among patients with CLE without IM, most (101, 94 % ) had a short segment of CLE. Repeat endo scopy was performed on 80 subjects within 2 years of the index endoscopy. Mean duration between endoscopies was 523 days (1.46 years). Th e rest of the subjects declined or did not show up for follow-up endoscopy.
Of the 80 subjects with CLE and no IM who underwent repeat endoscopy, 96 % were male, with an age distribution of 40 -49 (14 % ), 50 -59 (26 % ), 60 -69 (46 % ), and > 70 years (14 % ). Repeat endoscopy with esophageal biopsies showed that in 24 (30 % ; 95 % CI 20.0 -40.0 % ) subjects with suspected CLE and no IM was not confi rmed, 33 (41 % ; 95 % CI 30.2 -51.8 % ) subjects had endoscopically suspected BE (i.e., with CLE) that remained negative histopathology for IM, and 23 (29 % ; 95 % CI 19.1 % to 38.9 % ) subjects with suspected CLE had confi rmed BE on histopathology ( Figure 1 ). Of the subjects with suspected CLE and no IM, biopsies showed squamous epithelium in 20 (61 % , 95 % CI 50.3 % to 71.7 % ), columnar lined epithelium in 11 (33 % , 95 % CI 22.7 -43.3 % ), and gastric oxyntic mucosa in 2 (6 % , 95 % CI 0.8 -11.2 % ). Th ere was no dysplasia seen in any of the repeat biopsies in confi rmed BE. Nine of the repeat endoscopies were done by the endoscopist who performed the index procedure with an 89 % concordance of diagnosing suspected CLE, whereas 71 were done by a diff erent endoscopist with a concordance of 68 % . Th ere was no signifi cant diff erence in the proportions of patients with CLE and no IM or defi nitive BE according to the identity of the endoscopist.
Comparisons between the subjects with CLE and no IM and those with CLE and IM showed that there was no signifi cant diff erences in the two groups with respect to age, gender, race, body mass index, presence or duration of GERD, length of CLE, hiatal hernia, Hill fl ap valve classifi cation, or use of anti-secretory agents ( P > 0.1) ( Table 1 ) . Th e mean length of suspected CLE on index endoscopy in patients with defi nite BE was slightly longer but not statistically signifi cant (1.6 cm, s.d. 1.3) than those with suspected BE and no IM (1.5 cm, s.d. 1.4) or no CLE (1.4 cm, s.d. 1.2) on repeat EGD. Th e median suspected CLE length was 1 cm for both the groups. Th e interquartile range for the confi rmed BE group was 1 cm (interquartile range 1 -2 cm), and 1.5 for the no BE group (interquartile range 0.5 -2 cm). Testing the medians and distributions using nonparametric tests yielded non-signifi cant results, both for the groups as a whole (Mann -Whitney U : P = 0.33) and for the smaller groups when the lengths < 0.5 are excluded ( P = 0.51). Among patients with 0.5 cm of CLE on index exam , only 19.2 % showed defi nitive BE on repeat EGD. Th ere were no instances of surgical or endoscopic ablation in any of the study patients. Th ere were no signifi cant differences in the use of proton pump inhibitor between those with diff erent CLE lengths. Th e multivariable logistic regression adjusting for source of referral (endoscopy vs. PCP) there were no significant predictor factors of defi nitive BE on follow-up endoscopy.
DISCUSSION
In the present study, we determined the utility of repeating EGD in patients with endoscopic appearance of BE on index endoscopy (i.e., suspected CLE) with no histological confi rmation (i.e., no IM). We found that most patients (41 % ) continued to have a negative histopathology result or had no suspected CLE (30 % ), and only 29 % of the repeat evaluations showed biopsy-proven BE. Apart from a non-signifi cant trend toward longer length of CLE, we found no demographic or clinical predictors for the presence of defi nitive BE on repeat EGD. Th ese fi ndings support a recommendation of a second follow-up EGD aft er an initial diagnosis of CLE with no IM and also support a defi nition of BE that is based on histopathology in addition to endoscopic fi ndings.
We recommend considering a follow-up EGD in 2 -3 years following an index EGD showing suspected CLE without IM. Th is is based on the fi nding in our study that no cases of dysplasia or cancer were detected in up to 2 years follow-up. Th is is not currently recommended for or against by the current guidelines. Although we examined several risk factors for BE development, including old age, male sex, presence of GERD, Caucasian race, and abdominal obesity ( 9 ) , none predicted the presence of defi nite BE on repeat endoscopy among patients with an initial diagnosis of suspected CLE without IM. Th is poses a challenge in recognizing and thus in performing targeted repeat EGD to determine which of the suspected CLE cases would have a higher predictability of a positive IM histopathological diagnosis on repeat endoscopy. Given the relatively low confi rmation rate of BE on subsequent EGD, a strategy of repeat confi rmatory EGD is likely to be considerably cost eff ective than one that considers all suspected CLE for BE surveillance strategies. Among patients with 0.5 cm of suspected CLE on index exam, only 19 % showed IM-positive BE on repeat EGD. It is unclear whether or not endoscopy follow-up is required in these patients, especially given that the cancer risk associated with this ultra-short segment is considered very low.
CLE without IM seems to be a reproducible diagnosis in the setting of research studies. Th e one previous study that examined this showed that only approximately 11 % of the patients with suspected CLE and no IM had repeat positive IM histology confi rming 
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the diagnosis of BE ( 6 ). Our study showed a slightly higher proportion, but both studies show that the majority of CLE without IM cases will persist as such. It is unclear whether similar results will be shown in routine clinical practice, and it is possible that an initial diagnosis of suspected CLE without IM will be more frequently converted to defi nitive BE than what we reported. Th is concern further supports a recommendation of a second follow-up endoscopy within 2 -3 years of the index EGD. Reproducibility of endoscopic biopsy fi ndings may vary based on sampling methodology and BE segment length. Th e length of the suspected CLE segment seems to be the major determinant of the presence of IM. In our study, 72 % of patients with suspected CLE had a Prague C (circumferential) and M (maximal extent) ( 8 ) of < 3 cm compared with only 62 % of patients with defi nitive BE. Similarly, in the follow-up phase of our study there was a non-signifi cant trend toward longer CLE segment among those with defi nitive BE compared with the rest. Whether this association refers to true absence of IM or a sampling error is unclear. However, the persistent absence of IM on two successive EGDs argues against sampling error.
Defi ning BE based on endoscopic fi ndings of suspected BE including short segments will greatly infl ate the prevalence of BE without evidence of benefi t. In our study, approximately 7 out of the 10 diagnosed with endoscopic BE only did not have IM in two successive endoscopies, and none of the repeat biopsies with IM had evidence of dysplasia. A previous study looking at the presence of goblet cells in patients with suspected CLE found that only 19 % with CLE < 2 cm had goblet cells. Foregoing this requirement increased the diagnosis of BE by 147 % ( 10 ) .
Th e strengths of our study included the prospective design, the systematic recording of endoscopic landmarks and biopsy collection, the collection of information on several potential predictors, and the relatively large sample size of patients who underwent endoscopy. Biopsies from the index as well as repeat endoscopy biopsies were taken as per a pre-determined protocol and reviewed by two expert pathologists. Both procedures were done within a relatively short time interval to minimize the likelihood of new fi ndings and thus allow the proper examination of reproducibility. Furthermore, we tracked and analyzed the eff ect of having diff erent endoscopists performing these procedures. However, despite this, the interobserver variability in identifying suspected BE was low.
In summary, suspected CLE with no IM is relatively common among patients presenting to elective endoscopy, and this is a reproducible fi nding in approximately 70 % of cases. We recommend a second follow-up EGD in 2 -3 years to avoid missing the approximately 30 % of cases of defi nitive BE and unnecessary surveillance of the 70 % without defi nitive BE. BE, Barrett's esophagus; BMI, body mass index; CLE, columnar lined esophagus; GERD, gastro-esophageal refl ux; H2RA, histamine-2 receptor antagonist; IM, intestinal metaplasia; NSAID, non-steroidal anti-infl ammatory drug; PCP, primary care physician; PPI, proton pump inhibitor; WHR, waist-to-hip ratio. a High WHR is defi ned as > =0.9 in males and > =0.85 in females.
